Jennifer Viera | executive |
Jay Luly | executive |
Paul Mellett | executive |
Johoon Kim | analyst |
Emma Nesson | analyst |
Luke Herrmann | analyst |
Roanna Clarissa Ruiz | analyst |
Amy Li | analyst |
Matthew Hershenhorn | analyst |
Antonio Arce | analyst |
Eric Joseph | analyst |
Tara Kieffer | executive |
Roy Buchanan | analyst |
Good afternoon, and welcome to Enanta Pharmaceuticals Fiscal First Quarter Ended December 31, 2022 Financial Results Conference Call. [Operator Instructions]
Please be advised that today's conference is being recorded. I would now like to hand the conference over to Jennifer Viera, Investor Relations. Please go ahead.